Non‐24‐hour sleep‐wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder
Abstract Introduction Non‐24‐hour sleep‐wake disorder (N24SWD) is often observed in the visually impaired and those who isolate indoors. Melatonin receptor agonists may be used for treatment, but there is currently no evidence that they are effective in patients without visual impairment. Case We re...
Saved in:
Main Authors: | Masaaki Iwata (Author), Koichi Kaneko (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of combined use of Suvorexant and Ramelteon in preventing postoperative delirium: a retrospective comparative study
by: Shoya Ikeuchi, et al.
Published: (2023) -
Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: A randomized double‐blind study
by: Sachiko Ito Uemura, et al.
Published: (2022) -
Rethinking daily movement behaviors of children wth autism spectrum disorder: meeting the 24-hour movement guidelines
by: Sean Healy, et al.
Published: (2020) -
Assessment of Sleep in Children with Autism Spectrum Disorder
by: Makeda Moore, et al.
Published: (2017) -
Associations between meeting 24-hour movement guidelines and quality of life among children and adolescents with autism spectrum disorder
by: Chuidan Kong, et al.
Published: (2023)